The bio-medical industry is extremely dynamic. New equipment, new products are being developed as we speak. The „in vitro” diagnosis devices are no exception. This is an activity involving a great deal of challenges, efforts and enthusiasm but equally offering extraordinary outcomes and satisfactions.
For us, the main concern is to permanently improve our portfolio of products and obtain new diagnostic methods.
For the last 10 years, our research activity was focused on the development of biochips and immunosensors. Globally, this is a very significant trend considering the advantages of the biochips and immunosensors as diagnosis devices. They are easy to use, the throughput is quickly attained, and there is no need for sophisticated equipment or special working conditions. The analytic performances are highly superior to those of the current methods and, more importantly, the costs are lower.
The researches carried out in the biochip/immunosensors field, supported by the discovery of miniaturized test sites, revolutionised the medical industry worldwide. These new methods are multidisciplinary and incorporate the newest breakthroughs and technologies in the materials science, biochemistry, chemistry, molecular biology, information technology (TIC), electronics, microfluidics, biophysics.
The biochips/immunosensors are widely applied and used: „in vitro” diagnosis, genetics, „point of care” systems, proteomics, tissue and organ transplant, customised medicine, discovery of new medicines, biotechnology, environment, agriculture.
As shown by the „Research and Market” studies, „among the advantages in using bio-microsystems there are the integrated intelligence, the parallelism, the low cost, the redundancy and quick response. A biochip is an example of bio-microsystem; it is a collection of microarrays arranged on a solid substrate that can perform thousands of complex biochemical reactions, such as decoding genes, in a few seconds. Analysist predict that the global biochip market will develop to an annual growth rate of 17.02% during 2016-2020.
Article published by: Phd. Dana Stan